净收入 更改 日
AstraZeneca USD 3.12B 610M 2026-09
Genmab DKK 303M 250M 2026-06
GlaxoSmithKline GBP 1.54B 1.11B 2026-09
GRIFOLS EUR 162M 8M 2026-09
Hikma Pharmaceutical USD 164M 45M 2025-12
Lakefront Biotherapeutics EUR 2.11M 12.38M 2026-06
Qiagen NV USD 103.4M 35.36M 2026-06
UCB EUR 1.08B 608M 2025-12